The European Medicines Agency adopts new guidance on Adaptive Pathways

The European Medicines Agency (“EMA”) has published a new guidance document for companies that wish to participate in the Adaptive Pathways initiative (“New Guidance”). To read more, click here.


Download PDF Share Back To Listing
Loading data